Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,757 | 29,854 | 65,221 | 193,725 | 232,968 |
| Receivables | 233 | 131 | 71 | 248 | N/A |
| Inventories | 722 | 679 | 1,991 | 1,985 | N/A |
| Other current assets | 10,945 | 1,440 | 2,078 | 3,843 | 956 |
| TOTAL | $44,685 | $37,394 | $72,143 | $202,868 | $236,812 |
| Non-Current Assets | |||||
| PPE Net | 175 | 475 | 784 | 1,084 | 1,294 |
| Other Non-Current Assets | 56 | 469 | 775 | 1,901 | 1,333 |
| TOTAL | $231 | $944 | $1,559 | $2,985 | $2,627 |
| Total Assets | $44,916 | $38,338 | $73,702 | $205,853 | $239,439 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24,931 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 14,839 | 16,097 | 13,761 | 10,650 | 4,882 |
| Accrued Expenses | 4,341 | 5,762 | 12,424 | 18,669 | 11,492 |
| Other current liabilities | 9,815 | 374 | 346 | 404 | 293 |
| TOTAL | $53,926 | $22,233 | $27,267 | $32,898 | $16,667 |
| Non-Current Liabilities | |||||
| Long Term Debt | 84,663 | 102,508 | 100,598 | 93,051 | N/A |
| Other Non-Current Liabilities | 1,790 | 6,698 | 2,345 | 3,129 | 1,105 |
| TOTAL | $86,453 | $109,206 | $102,943 | $96,180 | $1,105 |
| Total Liabilities | $140,379 | $131,439 | $130,210 | $129,078 | $17,772 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,075 | 5,486 | 1,911 | 1,813 | 1,749 |
| Common Shares | 76 | 49 | 30 | 28 | 28 |
| Retained earnings | -720,094 | -650,197 | -590,598 | -411,545 | -245,788 |
| TOTAL | $-95,463 | $-93,101 | $-56,508 | $76,775 | $221,667 |
| Total Liabilities And Equity | $44,916 | $38,338 | $73,702 | $205,853 | $239,439 |